4th Quarter - Report
ALEXION PHARMACEUTICALS, INC. for ALEXION PHARMACEUTICALS, INC.
Income
—
Expenses
$105,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Korea/US Free Trade Agreement
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI L WAGNER | — |
Health Issues HCR
Monitor deficit reduction initiatives, including Budget Control Act of 2011 and "Super Committee" deliberations; Prescription Drug User Fee Act (PDUFA) Reathorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| HEIDI L WAGNER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.